SEHK:2268Life Sciences
WuXi XDC Cayman (SEHK:2268) Stock Rally Meets Backlog Fueled Growth
WuXi XDC Cayman stock has rallied hard into this print, with the shares up about 46% over the past three months and closing today at HK$77.25. The key question for investors is whether that optimism can survive an earnings reality check. The headline is clear: WuXi XDC Cayman delivered H1 2026 revenue of RMB 3.7b and an adjusted net margin of about 27.8%. That keeps the story anchored in growth for a high valuation stock that trades on execution and visibility.
Love WuXi XDC Cayman's high...